ETNHX Holdings — Eventide Healthcare & Life Sciences Fund
All 92 reported holdings of Eventide Healthcare & Life Sciences Fund (ETNHX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Guardant Health Inc | 4.07% | $64.69M |
| Mirum Pharmaceuticals Inc. | 4.02% | $63.82M |
| Insmed Inc | 3.78% | $60.04M |
| US Bank Mmda | 3.65% | $57.97M |
| BeLite Bio Inc | 3.30% | $52.40M |
| Kymera Therapeutics Inc | 3.28% | $52.14M |
| Vaxcyte Inc | 3.03% | $48.09M |
| Apogee Therapeutics Inc. | 2.96% | $46.92M |
| Ionis Pharmaceuticals, Inc. | 2.72% | $43.18M |
| Argenx SE | 2.26% | $35.92M |
| Abivax SA | 2.25% | $35.67M |
| Scholar Rock Holding Corp. | 2.23% | $35.34M |
| Celldex Therapeutics Inc. | 2.07% | $32.89M |
| iRhythm Holdings Inc. | 2.06% | $32.78M |
| Bridgebio Pharma Inc | 2.04% | $32.46M |
| Cytokinetics Inc | 1.99% | $31.57M |
| Trevi Therapeutics Inc | 1.97% | $31.28M |
| Palvella Therapeutics Inc. | 1.82% | $28.85M |
| Celcuity Inc. | 1.75% | $27.72M |
| Kestra Medical Technologies Ltd. | 1.72% | $27.27M |
| Axsome Therapeutics Inc. | 1.69% | $26.90M |
| MBX Biosciences, Inc. | 1.67% | $26.57M |
| Centessa Pharmaceuticals plc | 1.67% | $26.54M |
| Sionna Therapeutics Inc. | 1.63% | $25.84M |
| Disc Medicine Inc | 1.59% | $25.27M |
| First American Funds Inc. | 1.58% | $25.05M |
| Revolution Medicines Inc | 1.58% | $25.01M |
| CG Oncology Inc. | 1.56% | $24.80M |
| Immix Biopharma Inc | 1.46% | $23.22M |
| Arrowhead Pharmaceuticals Inc | 1.46% | $23.20M |
| Evommune Inc. | 1.36% | $21.61M |
| ADC Therapeutics SA | 1.35% | $21.38M |
| Amylyx Pharmaceuticals Inc | 1.32% | $21.02M |
| Beta Bionics Inc. | 1.30% | $20.56M |
| Nurix Therapeutics Inc. | 1.27% | $20.12M |
| Dianthus Therapeutics Inc | 1.19% | $18.90M |
| Sutro Biopharma Inc. | 1.12% | $17.82M |
| HeartFlow Inc. | 1.09% | $17.38M |
| United Therapeutics Corporation | 1.05% | $16.75M |
| Avalyn Pharma | 1.03% | $16.31M |
| Eyepoint Inc. | 1.01% | $16.06M |
| DexCom Inc | 1.00% | $15.86M |
| GeneDx Holdings Corp | 0.98% | $15.61M |
| Ovid Therapeutics, Inc. | 0.98% | $15.59M |
| Glaukos Corp. | 0.97% | $15.36M |
| Privia Health Group Inc. | 0.96% | $15.17M |
| Definium Therapeutics Inc. | 0.82% | $12.97M |
| Praxis Precision Medicines Inc | 0.78% | $12.34M |
| ORIC Pharmaceuticals Inc. | 0.76% | $12.05M |
| Invivyd Inc | 0.74% | $11.79M |
| Oculis Holding AG | 0.72% | $11.43M |
| Kardium Inc. | 0.63% | $10.00M |
| Bright Minds Biosciences Inc | 0.60% | $9.49M |
| Castle Biosciences Inc | 0.60% | $9.49M |
| Aktis Oncology Inc. | 0.57% | $9.07M |
| TransMedics Group Inc. | 0.52% | $8.21M |
| Corvus Pharmaceuticals Inc | 0.51% | $8.05M |
| Kardigan Inc | 0.50% | $8.00M |
| Cybin Inc | 0.43% | $6.77M |
| Ovid Therapeutics Inc | 0.40% | $6.43M |
| Evommune, Inc. | 0.39% | $6.18M |
| Relmada Therapeutics, Inc. | 0.37% | $5.86M |
| Evolent Health, Inc. | 0.37% | $5.81M |
| Edgewise Therapeutics Inc. | 0.30% | $4.72M |
| Belite Bio Inc | 0.29% | $4.63M |
| Pfizer, Inc. | 0.27% | $4.32M |
| Cytomx Therapeutics Inc | 0.27% | $4.23M |
| Fidelity Colchester Street Trust | 0.23% | $3.66M |
| Avalyn Pharma Inc Ser D | 0.20% | $3.23M |
| Ovid Therapeutics Inc | 0.18% | $2.94M |
| Casma Therapeutics Ii | 0.18% | $2.87M |
| Ovid Therapeutics Inc | 0.16% | $2.60M |
| Freenome Holdings, Inc. | 0.14% | $2.28M |
| Collegium Pharmaceutical Inc. | 0.13% | $2.11M |
| Peloton Therapeutics | 0.11% | $1.68M |
| Flare Therapeutics, Inc. | 0.09% | $1.50M |
| Flare Therapeutics Incorporated | 0.08% | $1.24M |
| Prometheus Biosciences | 0.06% | $980.82K |
| Casma Therapeutics | 0.03% | $401.93K |
| Casma Therapeutics | 0.03% | $401.93K |
| Freenome | 0.02% | $327.78K |
| Casma Therapeutics Ii | 0.01% | $199.35K |
| Casma Therapeutics, Inc. | 0.01% | $146.33K |
| Biosplice Therapeutics Inc. Series C | 0.01% | $83.21K |
| Goldfinch Biopharma, Inc. | 0.00% | $44.02K |
| Goldfinch Bio B2 | 0.00% | $26.58K |
| Goldfinch Bio, Inc. | 0.00% | $0 |
| Biosplice Therapeutics Inc. | 0.00% | $0 |
| Kojin Therapeutics, Inc. | 0.00% | $0 |
| Biosplice Therapeutics | 0.00% | $0 |
| Goldfinch Biopharma, Inc. | 0.00% | $0 |
| Kojin Therapeutics | 0.00% | $0 |
ETNHX overview: performance, fees, allocation and SEC filings